| EGFR | Epidermal growth factor receptor |
| EPR | Enhanced Permeation and Retention |
| HA | Hyaluronic acid |
| HCC | Hepatocellular carcinoma |
| HER2 | Human epidermal growth factor receptor 2 |
| HIF | Hypoxia-inducible factor |
| IC50 | Half maximal inhibitory concentration |
| MAPK | Mitogen-activated protein kinase |
| MEK | Mitogen-activated protein kinase |
| MTD | Maximum tolerated dose |
| PAMAM | Polyamidoamine |
| PARP | Poly (ADP-ribose) polymerase |
| PCL | Poly(ε-caprolactone) |
| PEI | Polyethylenimine |
| PEG | Polyethylene glycol |
| PI3K | Phosphatidylinositol-3-kinase |
| PLA | Poly-L-lactic acid |
| PLGA | Poly(lactic-co-glycolic acid) |
| PLL | Poly-L-lysine |
| PSMA | Prostate-specific membrane antigen |
| RAF | Rapidly Accelerated Fibrosarcoma |
| RTK | Receptor tyrosine kinase |
| siRNA | Small interfering Ribonucleic Acid |
| shRNA | Small hairpin Ribonucleic Acid |
| STAT | Signal transducer and activator of transcription |
| TPGS | D-α-Tocopheryl polyethylene glycol succinate |